Evaluation

Submitted by Anjali Fortna on Tue, 05/26/2015 - 2:46pm

Please rate this CME activity. *

	Very Poor	Poor	Neutral	Good	Excellent
Overall Evaluation	Overall Evaluation - Very Poor	Overall Evaluation - Poor	Overall Evaluation - Neutral	Overall Evaluation - Good	Overall Evaluation - Excellent
Content	Content - Very Poor	Content - Poor	Content - Neutral	Content - Good	Content - Excellent
Usefulness	Usefulness - Very Poor	Usefulness - Poor	Usefulness - Neutral	Usefulness - Good	Usefulness - Excellent
Quality	Quality - Very Poor	Quality - Poor	Quality - Neutral	Quality - Good	Quality - Excellent

Please rate the extent to which each of the following learning objectives were met. *

Please use the scale: 1=Strongly Disagree, 2=Disagree, 3=Neutral, 4=Agree, 5= Strongly Agree

	1	2	3	4	5
Review the histologic and progressive process of IPF, and examine treatment guidelines, diagnostic characteristics, and patient screening recommendations.	Review the histologic and progressive process of IPF, and examine treatment guidelines, diagnostic characteristics, and patient screening recommendations. - 1	Review the histologic and progressive process of IPF, and examine treatment guidelines, diagnostic characteristics, and patient screening recommendations. - 2	Review the histologic and progressive process of IPF, and examine treatment guidelines, diagnostic characteristics, and patient screening recommendations. - 3	Review the histologic and progressive process of IPF, and examine treatment guidelines, diagnostic characteristics, and patient screening recommendations. - 4	Review the histologic and progressive process of IPF, and examine treatment guidelines, diagnostic characteristics, and patient screening recommendations. - 5
Analyze current clinical trial within IPF, and identify the role of pharmacotherapies in treatment.	Analyze current clinical trial within IPF, and identify the role of pharmacotherapies in treatment. - 1	Analyze current clinical trial within IPF, and identify the role of pharmacotherapies in treatment. - 2	Analyze current clinical trial within IPF, and identify the role of pharmacotherapies in treatment. - 3	Analyze current clinical trial within IPF, and identify the role of pharmacotherapies in treatment. - 4	Analyze current clinical trial within IPF, and identify the role of pharmacotherapies in treatment. - 5
Develop personalized treatment plans to optimally address risk, adverse events, and overall quality of life for patients with IPF	Develop personalized treatment plans to optimally address risk, adverse events, and overall quality of life for patients with IPF - 1	Develop personalized treatment plans to optimally address risk, adverse events, and overall quality of life for patients with IPF - 2	Develop personalized treatment plans to optimally address risk, adverse events, and overall quality of life for patients with IPF - 3	Develop personalized treatment plans to optimally address risk, adverse events, and overall quality of life for patients with IPF - 4	Develop personalized treatment plans to optimally address risk, adverse events, and overall quality of life for patients with IPF - 5

After participating in this activity, how confident are you in: *

Please use the scale: 1=NOT at all confident, 2=Somewhat confident, 3=Confident, 4=Very confident, 5=EXTREMELY confident, N/A=Not within the scope of my practice

	1	2	3	4	5	N/A
applying current evidence-based guidelines for the diagnosis and management of patients with IPF?	applying current evidence-based guidelines for the diagnosis and management of patients with IPF? - 1	applying current evidence-based guidelines for the diagnosis and management of patients with IPF? - 2	applying current evidence-based guidelines for the diagnosis and management of patients with IPF? - 3	applying current evidence-based guidelines for the diagnosis and management of patients with IPF? - 4	applying current evidence-based guidelines for the diagnosis and management of patients with IPF? - 5	applying current evidence-based guidelines for the diagnosis and management of patients with IPF? - N/A
your ability to incorporate clinical trial data into personalized treatment strategies for patients with IPF?	your ability to incorporate clinical trial data into personalized treatment strategies for patients with IPF? - 1	your ability to incorporate clinical trial data into personalized treatment strategies for patients with IPF? - 2	your ability to incorporate clinical trial data into personalized treatment strategies for patients with IPF? - 3	your ability to incorporate clinical trial data into personalized treatment strategies for patients with IPF? - 4	your ability to incorporate clinical trial data into personalized treatment strategies for patients with IPF? - 5	your ability to incorporate clinical trial data into personalized treatment strategies for patients with IPF? - N/A

As a result of participating in this activity, I will consider current clinical trial data on therapeutic targets to improve outcomes of patients with IPF. *

Yes

Do you feel the activity was fair, balanced, and free of commercial bias? *

Yes

If no, please explain.

What topics would you like to see in future CME activities?

Do you wish to be notified by email when new educational programs are offered by Elsevier?

Yes

Please indicate how often you NOW PLAN to use each of the following practice strategies for your patients with IPF based on your participation in this activity. *

Please use the scale: 1=Never, 2=Not often, 3=Sometimes, 4=Often, 5=Always, N/A=Not applicable to me

	1	2	3	4	5	N/A
Utilize a multidisciplinary approach between pulmonologists, radiologists, and pathologists when evaluating suspected IPF	Utilize a multidisciplinary approach between pulmonologists, radiologists, and pathologists when evaluating suspected IPF - 1	Utilize a multidisciplinary approach between pulmonologists, radiologists, and pathologists when evaluating suspected IPF - 2	Utilize a multidisciplinary approach between pulmonologists, radiologists, and pathologists when evaluating suspected IPF - 3	Utilize a multidisciplinary approach between pulmonologists, radiologists, and pathologists when evaluating suspected IPF - 4	Utilize a multidisciplinary approach between pulmonologists, radiologists, and pathologists when evaluating suspected IPF - 5	Utilize a multidisciplinary approach between pulmonologists, radiologists, and pathologists when evaluating suspected IPF - N/A
Provide accurate information on all therapeutic options when discussing treatment plans with your patients with IPF	Provide accurate information on all therapeutic options when discussing treatment plans with your patients with IPF - 1	Provide accurate information on all therapeutic options when discussing treatment plans with your patients with IPF - 2	Provide accurate information on all therapeutic options when discussing treatment plans with your patients with IPF - 3	Provide accurate information on all therapeutic options when discussing treatment plans with your patients with IPF - 4	Provide accurate information on all therapeutic options when discussing treatment plans with your patients with IPF - 5	Provide accurate information on all therapeutic options when discussing treatment plans with your patients with IPF - N/A
Regularly identify microaspiration associated with gastroesophageal reflux as a risk factor for IPF	Regularly identify microaspiration associated with gastroesophageal reflux as a risk factor for IPF - 1	Regularly identify microaspiration associated with gastroesophageal reflux as a risk factor for IPF - 2	Regularly identify microaspiration associated with gastroesophageal reflux as a risk factor for IPF - 3	Regularly identify microaspiration associated with gastroesophageal reflux as a risk factor for IPF - 4	Regularly identify microaspiration associated with gastroesophageal reflux as a risk factor for IPF - 5	Regularly identify microaspiration associated with gastroesophageal reflux as a risk factor for IPF - N/A

Leave this field blank

Elsevier CME

Applying Recent Therapeutic Advancements into Personalized Treatment Plans in IPF

Evaluation

Pre-Activity Questions

Course Video

Post-Activity Test

Evaluation

30 Day Survey

Course navigation

You are here

Applying Recent Therapeutic Advancements into Personalized Treatment Plans in IPF

Evaluation

Pre-Activity Questions

Course Video

Post-Activity Test

Evaluation

30 Day Survey

Course navigation